Association between dietary sodium and potassium intake with chronic kidney disease in US adults: A cross-sectional study

American Journal of Nephrology

Volumn 37, Issue 6, 2013, Pages 526-533

  Sharma, Shailendra ^a   McFann, Kim ^a   Chonchol, Michel ^a   De Boer, Ian H ^c   Kendrick, Jessica ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Dietary potassium intake; Dietary sodium intake

Indexed keywords

ADULT; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MALE; POTASSIUM INTAKE; PRIORITY JOURNAL; RACE; SEX; SODIUM INTAKE; CROSS-SECTIONAL STUDY; MAJOR CLINICAL STUDY; RISK ASSESSMENT; UNITED STATES;

ADULT; ALBUMINURIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; POTASSIUM, DIETARY; RENAL INSUFFICIENCY, CHRONIC; SODIUM, DIETARY; UNITED STATES;

EID: 84877860449     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000351178     Document Type: Article

References (36)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Preva-lence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047. (Pubitemid 350074801)
2. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF: Secular trends in cardiovas-cular disease risk factors according to body mass index in US adults. JAMA 2005; 293: 1868-1874. (Pubitemid 40548183)
3. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79. (Pubitemid 36026281)
4. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J: Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011; 305:2532-2539.
5. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P: The burden of adult hype rtension in the United States 1999 to 2000: a rising tide. Hypertension 2004; 44: 398-404. (Pubitemid 39281486)
6. Hajjar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hyper-tension in the United States, 1988-2000. JAMA 2003; 290:199-206. (Pubitemid 37430058)
7. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovas-cular mortality risk in chronic kidney disease: comparison of traditional and novel risk fac-tors. JAMA 2005; 293:1737-1745.
8. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-conver-ting-enzyme inhibitor benazepril on the pro-gression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996; 334:939-945. (Pubitemid 26114159)
9. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G: Renoprotective properties of ACE-inhibition in non-diabetic nephropa-thies with non-nephrotic proteinuria. Lancet 1999; 354:359-364. (Pubitemid 29355751)
10. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, Collaborative Study Group: Reno-protective effect of angiotension-receptor an-tagonist irbesartan in patients with nephropa-thy due to type 2 diabetes. N Engl J Med 2001; 345:851-860.
11. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Col-laborative Study Group. N Engl J Med 1993; 329:1456-1462. (Pubitemid 23335891)
12. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of di-etary patterns on blood pressure. DASH Col-laborative Research Group. N Engl J Med 1997; 336:1117-1124.
13. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Chronic Kidney Disease Epidemiol-ogy Collaboration: Using standardized serum creatinine values in the Modification of Diet in the Renal Disease study equation for esti-mating glomerular filtration rate. Ann Intern Med 2006; 145:247-254. (Pubitemid 46768608)
14. Barton M, Vos I, Shaw S, Boer P D'Uscio LV, Gröne HJ, Rabelink TJ, Lattmann T, Moreau P Lüscher TF: Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hyp-ertension. J Am Soc Nephrol 2000; 11: 835-845.
15. Meng S, Roberts LJ 2nd, Cason GW, Curry TS, Manning RD Jr: Superoxide dismutase and oxidative stress in Dahl salt-sensitive and-re-sistant rats. Am J Physiol Regul Integr Comp Physiol 2002; 283:R732-R738. (Pubitemid 34951626)
16. Kitiyakara C, Chabrashvili T, Chen Y Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS: Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003; 14:2775-2782. (Pubitemid 37305640)
17. Weir MR, Dengel DR, Behrens MT, Goldberg AP: Salt-induced increases in systolic blood pressure affect renal hemodynamics and pro-teinuria. Hypertension 1995; 25:1339-1344.
18. Suckling RJ, He FJ, MacGregor GA: Altered dietary salt intake for preventing and treating diabetic kidney disease. The Cochrane Li-brary 2010; 12:CD006763.
19. Ekinci El, Thomas G, Thomas D, Johnson C, Macisaac RJ, Houlihan CA, Finch S, Panagi-otopoulos S, O'Callaghan C, Jerums G: Effects of salt supplementation on the albuminuric response to telmisartan with or without hy-drochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake. Diabetes Care 2009; 32:1398-1403.
20. Lin J, Hu FB, Curhan GC: Associations of diet with albuminuria and kidney function de-cline. Clin J Am Soc Nephrol 2010; 5:836-843.
21. Lin J, Fung TT, Hu FB, Curhan GC: Associa-tion of dietary patterns with albuminuria and kidney function decline in older white women: a subgroup analysis from the Nurses' Health Study. Am J Kidney Dis 2011; 57: 245-254.
22. Weir MR, Chrysant SG, McCarron DA, Canossa-Terris M, Cohen JD, Gunter PA, Lewin AJ, Mennella RF, Kirkegaard LW, Hamilton JH, et al: Influence of race and di-etary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives. Hypertension 1998; 31:1088-1096. (Pubitemid 28191502)
23. Lambers Heerspink HJ, Holtkamp FA, Parv-ing HH, Navis GJ, Lewis JB, Ritz E, de Graeff PA, de Zeeuw D: Moderation of dietary so-dium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int 2012; 82:330-337.
24. Thomas M, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Waden J, Tolonen N, Saraheimo M, Gordin D, et al; FinnDiane Study Group: The association between di-etary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Di-abetes Care 2011; 34:861-866.
25. Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK, Trials of Hypertension Preven-tion Collaborative Research Group: Joint ef-fects of sodium and potassium intake on sub-sequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med 2009; 169:32-40.
26. Young DB, Lin H, McCabe RD: Potassium's cardiovascular protective mechanisms. Am J Physiol 1995; 268:R825-R837
27. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 h urinary sodium and potassium excretion. In-tersalt Cooperative Research Group. BMJ 1988; 297:319-328.
28. Houston MC: The importance of potassium in managing hypertension. Curr Hypertens Rep 2011; 13:309-317.
29. Cappuccio FP, MacGregor GA: Does potas-sium supplementation lower blood pressure? A meta-analysis of published trials. J Hyper-tens 1991; 9:465-473.
30. Whelton PK, He J, Cutler JA, Brancati FL, Ap-pel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997; 277:1624-1632. (Pubitemid 27231195)
31. Dyer AR, Elliott P, Shipley M: Urinary elec-trolyte excretion in 24 h and blood pressure in the INTERSALT Study. II. Estimates of elec-trolyte-blood pressure associations corrected for regression dilution bias. The INTERSALT Cooperative Research Group. Am J Epidemi-ology 1994; 139:940-951. (Pubitemid 24138397)
32. Geleijnse JM, Kok FJ, Grobbee DE: Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomized trials. J Hum Hypertens 2003; 17:471-480. (Pubitemid 36903334)
33. Espeland MA, Kumanyika S, Wilson AC, Re-boussin DM, Easter L, Self M, Robertson J, Brown WM, McFarlane M, TONE Coopera-tive Research Group: Statistical issues in ana-lyzing 24-hour dietary recall and 24-hour urine collection data for sodium and potassium in-takes. Am J Epidemiol 2001; 153:996-1006. (Pubitemid 32423786)
34. Bazzano LA, He J, Ogden LG, Loria C, Vup-puturi S, Myers L, Whelton PK: Dietary po-tassium intake and risk of stroke in US men and women: National Health and Nutrition Examination Survey I epidemiologic follow-up study. Stroke 2001; 32:1473-1480.
35. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK: Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first Nation-al Health and Nutrition Examination Survey Epidemiologic Follow-Up Study. Arch Intern Med 2002; 162:1619-1624. (Pubitemid 34765011)
36. Yang Q, Liu T, Kuklina EV, Flanders WD, Hong Y, Gillespie C, Change MH, Gwinn M, Dowling N, Khoury MJ, Hu FB: Sodium and potassium intake and mortality among US adults: prospective data from the Third Na-tional Health and Nutrition Examination Sur-vey. Arch Intern Med 2011; 171:1183-1191. Kidney Disease Kidney Disease Kidney Disease